Literature DB >> 282948

The formation of tri-iodothyronine and reverse tri-iodothyronine from thyroxine in isolated rat renal tubules.

P Heyma, R G Larkins, J R Stockigt, D G Campbell.   

Abstract

1. Conversion of thyroxine into tri-iodothyronine and reverse tri-iodothyronine in intact cells was studied with isolated renal tubules prepared by collagenase digestion. 2. Conversion of thyroxine into tri-iodothyronine and reverse tri-iodothyronine increased progressively for at least 90 min. 3. Studies of tri-iodothyronine production from increasing amounts of thyroxine revealed that the thyroxine to tri-iodothyronine conversion is saturable. 4. Iodine and carbimazole had no effect on the thyroxine to tri-iodothyronine conversion. 5. 6-Propyl-2-thiouracil had a direct non-competitive inhibitory effect on the conversion of thyroxine into tri-iodothyronine with a 75% inhibition of the conversion at a propylthiouracil concentration within the therapeutic range in vivo. Propylthiouracil also inhibited the net formation of reverse tri-iodothyronine from thyroxine at a similar propylthiouracil concentration, as well as inhibiting the subsequent degradation of reverse tri-iodothyronine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 282948     DOI: 10.1042/cs0550567

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN: 0144-4107


  3 in total

1.  The effect of iodothyronines on the conversion of thyroxine into 3,3'-5-tri-iodothyronine in isolated rat renal tubules.

Authors:  P Heyma; R G Larkins; D G Campbell
Journal:  Biochem J       Date:  1980-08-15       Impact factor: 3.857

2.  D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine.

Authors:  P Heyma; R G Larkins; L Higginbotham; K W Ng
Journal:  Br Med J       Date:  1980-07-05

3.  Hepatic extraction and renal production of 3,3'-diiodothyronine and 3',5'-diiodothyronine in man.

Authors:  J Faber; O K Faber; B Lund; C Kirkegaard; J Wahren
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.